Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2026-01-09 @ 1:18 AM
Study NCT ID:
NCT00974233
Status:
COMPLETED
Last Update Posted:
2019-12-02
First Post:
2009-09-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL
Sponsor:
Organization: